Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 18;22(3):480.
doi: 10.3390/molecules22030480.

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer's Disease

Tosin A Olasehinde  1   2   3 , Ademola O Olaniran  4 , Anthony I Okoh  5   6
Affiliations
Review

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer's Disease

Tosin A Olasehinde et al. Molecules. .

Abstract

Current research is geared towards the discovery of new compounds with strong neuroprotective potential and few or no side effects compared to synthetic drugs. This review focuses on the potentials of extracts and biologically active compounds derived from microalgal biomass for the treatment and management of Alzheimer's disease (AD). Microalgal research has gained much attention recently due to its contribution to the production of renewable fuels and the ability of alga cells to produce several secondary metabolites such as carotenoids, polyphenols, sterols, polyunsaturated fatty acids and polysaccharides. These compounds exhibit several pharmacological activities and possess neuroprotective potential. The pathogenesis of Alzheimer's disease (AD) involves complex mechanisms that are associated with oxidative stress, cholinergic dysfunction, neuronal damage, protein misfolding and aggregation. The antioxidant, anticholinesterase activities as well as the inhibitory effects of some bioactive compounds from microalgae extracts on β-amyloid aggregation and neuronal death are discussed extensively. Phytochemical compounds from microalgae are used as pharmaceuticals, nutraceuticals and food supplements, and may possess neuroprotective potentials that are relevant to the management and/or treatment of AD.

Keywords: Alzheimer’s disease; bioactive compounds; cholinesterases; microalgae; neuroprotection; oxidative stress; β-secretase.

PubMed Disclaimer

Conflict of interest statement

The authors hereby declare no conflict of interest.

References

    1. Adefegha S.A., Oboh G., Olasehinde T.A. Alkaloid extracts from shea butter and breadfruit as potential inhibitors of monoamine oxidase, cholinesterases, and lipid peroxidation in rats’ brain homogenates: A comparative study. Comp. Clin. Pathol. 2016;25:1213–1219. doi: 10.1007/s00580-016-2331-0. - DOI
    1. Oboh G., Adewuni T.M., Ademosun A.O., Olasehinde T.A. Sorghum stem extract modulates Na+/K+-ATPase, ecto-5′-nucleotidase, and acetylcholinesterase activities. Comp. Clin. Pathol. 2016;25:749–756. doi: 10.1007/s00580-016-2259-4. - DOI
    1. Alzheimer’s Disease International . World Alzheimer’s Report 2015: The Global Impact of Dementia, An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer’s Disease International; London, UK: 2015. pp. 5–10.
    1. Oboh G., Olasehinde T.A., Ademosun A.O. Essential oil from lemon peels inhibit key enzymes linked to neurodegenerative conditions and pro-oxidant induced lipid peroxidation. J. Oleo Sci. 2014;63:373–381. doi: 10.5650/jos.ess13166. - DOI - PubMed
    1. Cortes N., Posada-Duque R.A., Alvarez R., Alzate F., Berkov S., Cardona-Gómez P.C., Osorio E. Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: A comparative study. Life Sci. 2015;122:42–50. doi: 10.1016/j.lfs.2014.12.011. - DOI - PubMed

MeSH terms